< Back
EMWA Logo EMWA Logo
 

Stefanie Rechtsteiner

Company:
Boehringer Ingelheim
Qualification:
Leader background:
Stefanie has worked for 15 years in various fields within the pharmaceutical industry. After several years in biotech and in sales she moved to pharmacovigilance where she specialised in safety writing from 2011 onwards. She has extensive hands-on experience on DSUR, RMP and PBRER writing and currently works as a senior pharmacovigilance writer at Boehringer Ingelheim. Stefanie joined EMWA in 2011 and is a member of the EMWA Finance Committee.
Workshops:
Post-submission Pharmacovigilance Writing: Interactions with Authorities and Impact on RMPs and PSURs
    Level: Advanced Area: Drug Development
    Code: DDA26 Duration: 03:30:00
Introduction to Pharmacovigilance Writing
    Level: Foundation Area: Drug Development
    Code: DDF32a Duration: 03:00:00
Writing Development Safety Update Reports
    Level: Advanced Area: Drug Development
    Code: DDA32 Duration: 03:30:00
Writing Development Safety Update Reports
    Level: Advanced Area: Drug Development
    Code: DDA32a Duration: 03:30:00